Paclitaxel Treatment Options

A collection of 2033 research studies where Paclitaxel is the interventional treatment. These studies are located in the United States. Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Combination Chemotherapy in Treating Patients With Bladder Cancer

NCT00003701

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether four-drug combination chemotherapy is more effective than two-drug combination chemotherapy in treating bladder cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two combination chemotherapy regimens in treating patients who have bladder cancer.

Gender:

ALL

Ages:

Between 0 years and 120 years

Trial Updated:

06/13/2023

Locations: Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia +12 locations

Conditions: Bladder Cancer, Urethral Cancer

Learn More ›

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

NCT01964430

Completed

The purpose of this study is to compare whether there is a delay or prevention of recurrence or death in participants with surgically removed pancreatic cancer who then take nab-Paclitaxel in combination with gemcitabine compared to those who take gemcitabine alone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/13/2023

Locations: Local Institution - 043, Scottsdale, Arizona +340 locations

Local Institution - 043, Scottsdale, Arizona

Mayo Clinic - Arizona, Scottsdale, Arizona

UCSD Moores Cancer Center, La Jolla, California

University of Southern California, Los Angeles, California

Local Institution - 044, Sacramento, California

UC Davis Cancer Center, Sacramento, California

Local Institution - 001, San Francisco, California

University of California, San Francisco Cutaneous Oncology and Melanoma Center, San Francisco, California

University of California Los Angeles, Santa Monica, California

University of Colorado Cancer Center, Aurora, Colorado

Local Institution - 059, Denver, Colorado

Rocky Mountain Cancer Centers, LLP [Denver-Midtown], Denver, Colorado

Yale Cancer Center, New Haven, Connecticut

Local Institution - 022, Boca Raton, Florida

Lynn Cancer Institute, Boca Raton, Florida

Florida Cancer Institute Cancer Spec, Fort Myers, Florida

Local Institution - 031, Fort Myers, Florida

Gainesville Heme Oncology Associates, Gainesville, Florida

Local Institution - 011, Gainesville, Florida

University of Florida, Gainesville, Florida

University of Miami and Sylvester Cancer Center, Miami, Florida

Florida Hospital Cancer Institute, Orlando, Florida

Local Institution - 039, Orlando, Florida

H Lee Moffitt Cancer Center, Tampa, Florida

Georgia Cancer Specialist, Atlanta, Georgia

University of Chicago Medical Center, Chicago, Illinois

Northshore University Healthsystem Research Institute, Evanston, Illinois

Illinois Cancer Specialists, Niles, Illinois

University of Louisville, Louisville, Kentucky

Ochsner Clinic Foundation, New Orleans, Louisiana

Ochsner Medical Center - Jefferson Highway, New Orleans, Louisiana

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel-Deaconess Medical Center, Boston, Massachusetts

Local Institution - 040, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Local Institution - 045, Boston, Massachusetts

Local Institution - 036, Ann Arbor, Michigan

University of Michigan, Ann Arbor, Michigan

Karmanos Cancer Center Wayne State University, Detroit, Michigan

Local Institution - 021, Rochester, Minnesota

Mayo Clinic, Rochester, Minnesota

Local Institution - 048, Omaha, Nebraska

Nebraska Methodist Hospital, Omaha, Nebraska

Local Institution - 064, Basking Ridge, New Jersey

MSKCC Basking Ridge, Basking Ridge, New Jersey

Saint Barnabas Medical Center, Livingston, New Jersey

Local Institution - 025, Buffalo, New York

Roswell Park Cancer Institute, Buffalo, New York

Memorial Sloan-Kettering Cancer Center, Commack, New York

Memorial Sloan Kettering Cancer Center West Harrison, Harrison, New York

NYU Langone Medical Center, Lake Success, New York

Local Institution - 008, New York, New York

Memorial Sloan-Kettering Cancer Center - NYC, New York, New York

Columbia University Medical Center, New York, New York

Local Institution - 032, New York, New York

Local Institution - 013, Rochester, New York

University of Rochester Cancer Center, James P. Wilmot Cancer Center, Rochester, New York

Local Institution - 066, Rockville Center, New York

MSKCC at Mercy Medical Center Mercy RockvilleCenter, Rockville Center, New York

MSKCC at Phelps Memorial Hospital Center. Phelps Sleepy Hollow, Sleepy Hollow, New York

State University of New York Upstate Medical Center, Syracuse, New York

Local Institution - 051, Winston-Salem, North Carolina

Wake Forest Univ. Health Sciences Outpatient Comprehensive Cancer Center, Winston-Salem, North Carolina

Local Institution - 030, Cincinnati, Ohio

Oncology Hematology Care, Inc., Cincinnati, Ohio

University of Cincinnati Medical CenterDivsion of Hematology OncologyThe Barrett Center, Cincinnati, Ohio

Case Western Reserve Center, Cleveland, Ohio

Local Institution - 047, Cleveland, Ohio

Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio

Cleveland Clinic Foundation IRB, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Local Institution - 020, Cleveland, Ohio

Local Institution - 054, Cleveland, Ohio

Local Institution - 005, Columbus, Ohio

Ohio State University Medical Center, Columbus, Ohio

Local Institution - 049, Oklahoma City, Oklahoma

University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma

Local Institution - 019, Portland, Oregon

Oregon Health and Science University OHSU, Portland, Oregon

Local Institution - 016, Philadelphia, Pennsylvania

Thomas Jefferson University, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Local Institution - 027, Pittsburgh, Pennsylvania

UPMC Cancer Pavillion, Pittsburgh, Pennsylvania

Chattanooga Oncology Hematology Care, Chattanooga, Tennessee

Local Institution - 023, Chattanooga, Tennessee

Local Institution - 004, Nashville, Tennessee

Sarah Cannon Research Inst, Nashville, Tennessee

Local Institution - 002, Nashville, Tennessee

Vanderbilt- Ingram Cancer Center, Nashville, Tennessee

Texas Oncology, Dallas, Texas

Baylor Sammons Cancer Center, Dallas, Texas

Local Institution - 062, Dallas, Texas

Local Institution - 010, Dallas, Texas

UT Southwestern Medical Center, Dallas, Texas

Local Institution - 050, Fort Worth, Texas

The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth, Texas

Baylor College of Medicine, Houston, Texas

Local Institution - 041, Houston, Texas

Texas Oncology, P.A. - Tyler, Tyler, Texas

Local Institution - 038, Charlottesville, Virginia

University of Virginia, Charlottesville, Virginia

Local Institution - 003, Seattle, Washington

Seattle Cancer Care Alliance - Seattle, Seattle, Washington

Virginia Mason Cancer Center, Seattle, Washington

Local Institution - 014, Madison, Wisconsin

University of Wisconsin - Madison Cancer Center, Madison, Wisconsin

Canberra Hospital, Garran, Australian Capital Territory

Local Institution - 505, Garran, Australian Capital Territory

Local Institution - 501, Darlinghurst, New South Wales

Local Institution - 507, St Leonards, New South Wales

Northern Cancer Institute, St Leonards, New South Wales

Local Institution - 504, Herston, Queensland

ICON Cancer Center, Milton, Queensland

Local Institution - 502, Milton, Queensland

Local Institution - 506, Bentleigh East, Victoria

Local Institution - 508, Subiaco, Western Australia

St John of God Subiaco Hospital, Subiaco, Western Australia

Monash Medical Centre Moorabbin Campus, Bentleigh East, Not set

Saint Vincent's Hospital, Darlinghurst, Not set

Austin Hospital, Heidelberg, Not set

Local Institution - 509, Heidelberg, Not set

Royal Brisbane and Women's Hospital, Herston, Not set

Cabrini Hospital, Malvern, Not set

Local Institution - 503, Malvern, Not set

Local Institution - 500, Randwick, Not set

Prince of Wales Hospital, Randwick, Not set

The Queen Elizabeth Hospital, Woodville South, Not set

Local Institution - 205, Graz, Not set

Medical University of Graz, Graz, Not set

Local Institution - 203, Innsbruck, Not set

Medical University Innsbruck, Innsbruck, Not set

Hospital of Elisabethinen Linz, Linz, Not set

Local Institution - 206, Linz, Not set

Local Institution - 204, Salzburg, Not set

Salzburger Landkliniken St. Johanns-Spital, Salzburg, Not set

Klinikum Wels-Grieskirchen GmbH, Wels, Not set

Local Institution - 0207, Wels, Not set

Hospital Wiener Neustadt, Wiener Neustadt, Not set

Local Institution - 202, Wiener Neustadt, Not set

Local Institution - 200, Wien, Not set

Medizinische Universitat Wien, Wien, Not set

Kaiser-Franz-Josef Spital, Wien, Not set

Local Institution - 201, Wien, Not set

Hopital Erasme, Brussels, Not set

Local Institution - 211, Brussels, Not set

UZ Antwerpen, Edegem, Not set

Local Institution - 213, Gent, Not set

UZ Gent, Gent, Not set

Local Institution - 210, Leuven, Not set

UZ Leuven, Leuven, Not set

Local Institution - 102, Calgary, Alberta

Tom Baker Cancer Center, Calgary, Alberta

Local Institution - 101, Toronto, Ontario

Sunnybrook Health Sciences Centre, Toronto, Ontario

Local Institution - 100, Toronto, Ontario

Princess Margaret Hospital, Toronto, Ontario

Centre Hospitalier de L'Universite de Montreal St-Luc, Montreal, Quebec

Local Institution - 104, Montreal, Quebec

Jewish General Hospital, Montreal, Quebec

Local Institution - 103, Montreal, Quebec

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set

Local Institution - 220, Hradec Kralove, Not set

Krajska nemocnice Liberec, a.s., Liberec, Not set

Krajska nemocnice T. Bati a.s., Zlin, Not set

Local Institution - 221, Zlin, Not set

Hæmatologisk afd. B Aalborg Sygehus Syd, Aalborg, Not set

Local Institution - 231, Aalborg, Not set

Herlev Hospital, Herlev, Not set

Local Institution - 232, Herlev, Not set

Local Institution - 230, Odense C, Not set

Onk.Dep., Odense Universitets hospital, Odense C, Not set

Local Institution - 240, Tampere, Oulun Lääni

Helsingin yliopistollinen keskussairaala, Helsinki, Not set

Local Institution - 241, Helsinki, Not set

Tampereen yliopistollinen sairaala, Tampere, Not set

Local Institution - 242, Turku, Not set

Turku University Hospital, Turku, Not set

Center Hospitalier Universitaire d' Angers, Angers cedex 09, Not set

Local Institution - 253, Angers cedex 09, Not set

Hopital Henri Mondor, Creteil, Not set

CHRU de Lille France, Lille, Not set

Local Institution - 257, Lille, Not set

Hopital Edouard Herriot - Hepato-gastroenterologie, Lyon Cedex 3, Not set

Local Institution - 258, Lyon Cedex 3, Not set

Hopital prive Jean Mermoz, Lyon, Not set

Local Institution - 252, Lyon, Not set

Hopital Europeen Georges Pompidou, Paris, Not set

Local Institution - 250, Paris, Not set

Hopital Saint Antoine, Paris, Not set

Hopital Pitie Salpetriere, Paris, Not set

Local Institution - 259, Paris, Not set

CHU La Miletrie, Poitiers Cedex, Not set

Local Institution - 251, Poitiers Cedex, Not set

Local Institution - 256, Toulose, Not set

Pole Des Specialites Medicales, Hopital Purpan, Toulose, Not set

Klinikum Weiden, Bayern, Not set

Local Institution - 280, Bayern, Not set

Charite - Universitätsmedizin Berlin, Berlin, Not set

Local Institution - 272, Berlin, Not set

Local Institution - 278, Dresden, Not set

Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Not set

Kliniken Essen-Mitte, Essen, Not set

Local Institution - 277, Frankfurt, Not set

Universitatsklinkum Frankfurt, Frankfurt, Not set

Local Institution - 284, Frechen, Not set

Praxis Internistischer Onkologie und Hamatologie Frechen, Frechen, Not set

Local Institution - 275, Friedrichshafen, Not set

Praxis für Innere Medizin, Dr.Oettle Helmut, Friedrichshafen, Not set

Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Not set

Local Institution - 279, Greifswald, Not set

Local Institution - 273, Hamburg, Not set

Universitaetsklinik Hamburg - Eppendorf, Hamburg, Not set

Local Institution - 281, Köln, Not set

Praxis Internistischer Onkologie und Hamatologie Koln, Köln, Not set

Local Institution - 274, Magdeburg, Not set

Universitatsklinik Magdeburg, Magdeburg, Not set

Klinikum der Johannes Gutenberg Uniervsitaet ,Haematologie, Mainz, Not set

Local Institution - 283, Mainz, Not set

Klinikum der Universitat Munchen-Grosshadern, München, Not set

Local Institution - 282, München, Not set

Klinikum Neuperlach, München, Not set

Local Institution - 276, München, Not set

Local Institution - 0271, Tübingen, Not set

University of Tubingen, Tübingen, Not set

Local Institution - 270, Würzburg, Not set

Universitatsklinikum Würzburg, Würzburg, Not set

Local Institution - 601, Hong Kong, Not set

Queen Mary Hospital, Hong Kong, Not set

Tuen Mun Hospital, Hong Kong, Not set

Local Institution - 602, Sha Tin, Not set

Prince of Wales Hospital the Chinese University of Hong Kong, Sha Tin, Not set

Fovarosi Szent Istvan es Szent Laszlo Korhaz es Rendelointezet, Budapest, Not set

Local Institution - 293, Budapest, Not set

Local Institution - 291, Budapest, Not set

Uzsoki Utcai Korhaz, Budapest, Not set

Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Debrecen, Not set

Local Institution - 290, Debrecen, Not set

Local Institution - 292, Gyor, Not set

Petz Aladar Megyei Oktato Korhaz,II. Belgyogyaszat, Gyor, Not set

Local Institution - 295, Szeged, Not set

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Szent-Gyorgyi Albert TE AOK Borgyogy, Szeged, Not set

Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Not set

Local Institution - 311, Cork, Not set

Cork University Hospital, Cork, Not set

Local Institution - 310, Dublin 4, Not set

St Vincent's University Hospital, Dublin 4, Not set

Local Institution - 329, Terni, Umbria

Local Institution - 325, Ancona, Not set

Ospedali Riuniti Umberto I GM Lancisi, Ancona, Not set

Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Not set

Local Institution - 330, Bologna, Not set

Azienda Ospedaliero-Universitaria Careggi, Firenze, Not set

Local Institution - 328, Firenze, Not set

Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori (I.R.S.T.), Meldola, Not set

Local Institution - 331, Meldola, Not set

Local Institution - 321, Milano, Not set

Ospedale San Raffaele S.r.l., Milano, Not set

Azienda Ospedaliera Niguarda Ca Granda, Milano, Not set

Local Institution - 322, Milano, Not set

Azienda Ospedaliero-Universitaria Pisana, Pisa, Not set

Local Institution - 324, Pisa, Not set

Arcispedale Santa Maria Nuova, Reggio Emilia, Not set

Local Institution - 333, Reggio Emilia, Not set

Local Institution - 323, Roma, Not set

Local Institution - 327, Roma, Not set

Policlinico Universitario Agostino Gemelli, Roma, Not set

Istituto Nazionale Tumori Regina Elena, Roma, Not set

Istituto Clinico Humanitas, Rozzano (MI), Not set

Local Institution - 326, Rozzano (MI), Not set

IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Not set

Local Institution - 332, San Giovanni Rotondo, Not set

Azienda Ospedaliera S Maria di Terni, Terni, Not set

Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Not set

Local Institution - 320, Verona, Not set

Local Institution - 641, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Local Institution - 642, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Asan Medical Center, Seoul, Not set

Local Institution - 640, Seoul, Not set

Academisch Medisch Centrum Amsterdam, Amsterdam, Not set

Local Institution - 400, Amsterdam, Not set

Catharina Hospital, Eindhoven, Not set

Local Institution - 403, Eindhoven, Not set

Isala Klinieken, Zwolle, Not set

Local Institution - 402, Zwolle, Not set

Centro Hospitalar de Lisboa Central - Hospital de Santo António dos Capuchos, Lisboa, Not set

Local Institution - 340, Lisboa, Not set

Hospital Da Luz, Lisboa, Not set

Local Institution - 341, Lisboa, Not set

Hospital de Sao Joao, Porto, Not set

Local Institution - 342, Porto, Not set

Local Institution - 610, Singapore, Not set

National University Hospital, Singapore, Not set

Local Institution - 611, Singapore, Not set

National Cancer Center, Singapore, Not set

Local Institution - 371, Santander, Cantabria

Local Institution - 360, Barcelona, Not set

Clinic Barcelona Hospital Universitari, Barcelona, Not set

Local Institution - 363, Barcelona, Not set

Instituto Catalan de Oncologia-Hospital Duran, Barcelona, Not set

Local Institution - 370, Barcelona, Not set

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital General Gregorio Maranon, Madrid, Not set

Local Institution - 367, Madrid, Not set

Local Institution - 362, Madrid, Not set

Ramon y Cajal Univeresity Hospital, Madrid, Not set

Hospital Clinico San Carlos, Madrid, Not set

Local Institution - 372, Madrid, Not set

Hospital 12 de Octubre, Madrid, Not set

Local Institution - 365, Madrid, Not set

Centro Integral, Madrid, Not set

Local Institution - 361, Madrid, Not set

Hospital General Carlos Haya, Malaga, Not set

Local Institution - 369, Malaga, Not set

Complejo Hospitalario de Navarra, Pamplona/ Navarra, Not set

Local Institution - 368, Pamplona/ Navarra, Not set

Hospital Universitario Marques de Valdecilla, Santander, Not set

Hospital Clinico Universitario De Santiago De Compostela, Santiago De Compostela, Not set

Local Institution - 366, Santiago De Compostela, Not set

Hospital Virgen del Rocio, Sevilla, Not set

Local Institution - 364, Sevilla, Not set

Local Institution - 620, Taichung, Not set

Taichung Veterans General Hospital, Taichung, Not set

Local Institution - 625, Tainan, Taiana, Not set

National Cheng Kung University Hospital, Tainan, Taiana, Not set

Local Institution - 623, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Tri-Service General Hospital, Taipei, Not set

Local Institution - 622, Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Not set

Local Institution - 624, Taoyuan, Not set

Local Institution - 621, Tapei, Not set

National Taiwan University Hospital, Tapei, Not set

Addenbrookes Hospital, Cambridge, Not set

Local Institution - 382, Cambridge, Not set

Glasgow Royal Infirmary, Glasgow, Not set

Local Institution - 380, Glasgow, Not set

Weston Park Hospital, Sheffield South Yorkshire, Not set

Local Institution - 381, Sheffield, Not set

Conditions: Pancreatic Neoplasms, Digestive System Neoplasms, Neoplasms by Site, Neoplasms, Endocrine Gland Neoplasms, Pancreatic Diseases, Digestive System Diseases, Endocrine System Diseases, Gemcitabine, Antimetabolites, Antineoplastic

Learn More ›

Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer

NCT00033657

Completed

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy before and after surgery may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of combining radiation therapy with two different chemotherapy regimens before and after surgery in treating patients who have esophageal cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/13/2023

Locations: CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado +22 locations

CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado

CCOP - Christiana Care Health Services, Newark, Delaware

Shands Cancer Center at the University of Florida Health Science Center, Gainesville, Florida

Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois

CCOP - Carle Cancer Center, Urbana, Illinois

CCOP - Iowa Oncology Research Association, Des Moines, Iowa

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan

Mayo Clinic Cancer Center, Rochester, Minnesota

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

St. Joseph's Hospital, Saint Paul, Minnesota

Cancer Institute of New Jersey at Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Ireland Cancer Center, Cleveland, Ohio

MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio

CCOP - Toledo Community Hospital, Toledo, Ohio

CCOP - MainLine Health, Wynnewood, Pennsylvania

Lankenau Cancer Center at Lankenau Hospital, Wynnewood, Pennsylvania

CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota

CCOP - Scott and White Hospital, Temple, Texas

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin

Conditions: Esophageal Cancer, Gastric Cancer

Learn More ›

Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial

NCT03003546

Completed

This phase I trial studies the best dose and side effects of paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel)/rituximab-coated nanoparticle AR160 in treating patients with B-cell non-Hodgkin lymphoma that has come back (relapsed) or is not responding to treatment (refractory). Nab-paclitaxel/rituximab-coated nanoparticle AR160 is a combination of paclitaxel albumin-stabilized nanoparticle formulation and rituximab. Drugs used in chemotherapy, such as paclitaxel albumin-sta... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/13/2023

Locations: Mayo Clinic in Rochester, Rochester, Minnesota

Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Small Lymphocytic Lymphoma, Recurrent Aggressive Non-Hodgkin Lymphoma, Refractory Aggressive Non-Hodgkin Lymphoma

Learn More ›

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

NCT00006004

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective for treating non-small cell lung cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of two combination chemotherapy regimens in treating patients who have non-small cell lung cancer.

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

06/13/2023

Locations: Emory University Hospital - Atlanta, Atlanta, Georgia +15 locations

Conditions: Lung Cancer

Learn More ›

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

NCT00003614

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel plus estramustine in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Gender:

MALE

Ages:

Between 18 years and 120 years

Trial Updated:

06/13/2023

Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois +27 locations

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois

Veterans Affairs Medical Center - Chicago (Lakeside), Chicago, Illinois

CCOP - Central Illinois, Decatur, Illinois

CCOP - Illinois Oncology Research Association, Peoria, Illinois

CCOP - Carle Cancer Center, Urbana, Illinois

Indiana University Hospitals, Indianapolis, Indiana

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa

CCOP - Ochsner, New Orleans, Louisiana

New England Medical Center Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

CCOP - Kalamazoo, Kalamazoo, Michigan

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey

CCOP - Northern New Jersey, Hackensack, New Jersey

University of Rochester Cancer Center, Rochester, New York

CCOP - Merit Care Hospital, Fargo, North Dakota

Ireland Cancer Center, Cleveland, Ohio

CCOP - Geisinger Clinical and Medical Center, Danville, Pennsylvania

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

CCOP - MainLine Health, Wynnewood, Pennsylvania

Veterans Affairs Medical Center - Madison, Madison, Wisconsin

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin

Pretoria Academic Hospital, Pretoria, Not set

Conditions: Prostate Cancer

Learn More ›

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

NCT00002632

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with metastatic or recurrent salivary gland cancer.

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

06/13/2023

Locations: Veterans Affairs Medical Center - Palo Alto, Palo Alto, California +28 locations

Veterans Affairs Medical Center - Palo Alto, Palo Alto, California

Stanford University Medical Center, Stanford, California

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois

Veterans Affairs Medical Center - Chicago (Lakeside), Chicago, Illinois

CCOP - Carle Cancer Center, Urbana, Illinois

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa

CCOP - Iowa Oncology Research Association, Des Moines, Iowa

Johns Hopkins Oncology Center, Baltimore, Maryland

CCOP - Ann Arbor Regional, Ann Arbor, Michigan

CCOP - Duluth, Duluth, Minnesota

University of Minnesota Cancer Center, Minneapolis, Minnesota

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey

CCOP - Northern New Jersey, Hackensack, New Jersey

Albert Einstein Comprehensive Cancer Center, Bronx, New York

University of Rochester Cancer Center, Rochester, New York

Ireland Cancer Center, Cleveland, Ohio

Hahnemann University Hospital, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Veterans Affairs Medical Center - Nashville, Nashville, Tennessee

Vanderbilt Cancer Center, Nashville, Tennessee

Veterans Affairs Medical Center - Madison, Madison, Wisconsin

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

Pretoria Academic Hospital, Pretoria, Not set

Conditions: Head and Neck Cancer

Learn More ›

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NCT02855944

Completed

The purpose of this study is to determine how patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib versus chemotherapy.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

06/07/2023

Locations: Rocky Mountain Cancer Center, Denver, Colorado +76 locations

Rocky Mountain Cancer Center, Denver, Colorado

Augusta University, Augusta, Georgia

Hospital Haroldo Juacaba Instituto do Cancer do Ceara, Fortaleza, Ceara

Instituto de Oncologia do Parana (IOP), Curitiba, Parana

União Brasileira de Educação e Assistência / Hospital São Lucas da PUCRS, Porto Alegre, RIO Grande DO SUL

CEPON-Centro de pesquisas Oncologicas, Florianópolis, Santa Catarina

Hospital do Cancer de Barretos, Barretos, SAO Paulo

Instituto Nacional de Câncer Hospital do Câncer II, Rio de Janeiro, Not set

Hospital Pérola Byington - Centro de Referência da Saúde da Mulher, Sao Paulo, Not set

Hospital São Camilo, Sao Paulo, Not set

Tom Baker Cancer Center, Calgary, Alberta

The Ottawa Hospital - General Campus, Ottawa, Ontario

Princess Margaret Hospital, Toronto, Ontario

Centre Hospitalier de L'Universite de Montreal (CHUM), Montreal, Quebec

CIUSSS de l'Estrie CHUS, Sherbrooke, Quebec

Masarykuv Onkologicky Ustav, Oddeleni komplexni klinicke onkologie, Brno, Jihormoravsky KRAJ

Fakultni Nemocnice v Motole, Praha 5, Praha

Fakultní Nemocnice Ostrava, Ostrava, Not set

Všeobecná Fakultní Nemocnice v Praze, Praha, Not set

Debreceni Egyetem Klinikai Központ, Debrecen, Hajdu-bihar

Országos Onkológiai Intézet, Budapest, Not set

Carmel Medical Center, Haifa, Not set

Edith Wolfson Medical Center, Holon, Not set

Hadassah Medical Organization, Jerusalem, Not set

Rabin Medical Center, Petach-Tikva, Not set

Chaim Sheba Medical Center, Ramat Gan, Not set

Tel Aviv Sourasky Medical Center, Oncology Dept., Tel Aviv, Not set

Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Not set

Istituto per la Ricerca e la Cura del Cancro Istituto di Candiolo, Candiolo, Not set

AO per l'emergenza Cannizzaro, Catania, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set

Istituto Europeo di Oncologia, Milano, Not set

Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Not set

Istituto Nazionale per lo studio e la cura dei tumori "Fondazione Pascale" Oncologia Medica, Napoli, Not set

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Not set

Niepubliczny Zaklad Opieki Zdrowotnej Innowacyjna Medycyna Sp z o.o., Grzybnica, West Pomeranian Voivodeship

Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie, Bialystok, Not set

Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin, Not set

Wojewodzki Szpital Specjalistyczny w Olsztynie, Olsztyn, Not set

Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Pozna, Poznan, Not set

Pomorska Akademia Medyczna w Szczecinie, Samodzielny Publiczny Szpital Kliniczny Nr 2, Szczecin, Not set

Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Not set

Kursk Regional Oncologic Dispensary, Kursk, Not set

Moscow Clinical Scientific and Practical Center of Moscow Healthcare Department, Moscow, Not set

Omsk Region Clinical Oncologic Dispensary, Omsk, Not set

Pyatigorsk Oncological Dispensary, Pyatigorsk, Not set

Ryazan Regional Clinical Oncology Dispensary, Ryazan, Not set

Pavlov First Saint-Petersburg State Medical University, Saint Petersburg, Not set

State Healthcare Institution Oncologic Dispensary No. 2 - Health Department of Krasnodar Region, Saint Petersburg, Not set

Saint Petersburg City Oncological Dispensary, Saint-Petersburg, Not set

Republican oncological dispensary of Republic of Mordovia, Saransk, Not set

State Healthcare Institution Oncologic Dispensary No. 2 - Health Department of Krasnodar Region, Sochi, Not set

Republic Clinical Oncology Dispensary of the Ministry of Healthcare of Republic of Bashkortostan, Ufa, Not set

Hospital Duran i Reynals, Barcelona, Not set

Hospital Universitari Vall DHebron, Barcelona, Not set

Hospital Universitari de Girona Doctor Josep Trueta, Girona, Not set

Centro Oncologico Regional de Galicia, La Coruna, Not set

Hospital Clinico San Carlos, Madrid, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

MD Anderson Cancer Center, Madrid, Not set

Universidad Autonoma de Madrid (UAM) - Hospital Universitario La Paz, Madrid, Not set

Dnipropetrovsk City Multifield Clinical Hospital Number 4, Dnipropetrovsk, Not set

National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Not set

Volyn Regional Oncology Dispensary, Lutsk, Not set

Lviv Regional Oncology Dispensary, Lviv, Not set

Sumy Regional Oncology Center, Sumy, Not set

Zakarpattya Regional Clinical Oncological Dispensary, Uzhgorod, Not set

The Christie NHS Foundation Trust - Clinical Trial Pharmacy, Manchester, England

The Royal Marsden NHS Foundation Trust, Sutton, Surrey

Cambridge University Hospitals NHS Foundation Trust, Cambridge, Not set

Velindre NHS Trust, Cardiff, Not set

University Hospital of Coventry and Warwickshire NHS Trust, Coventry, Not set

Derby Teaching Hospital NHS Foundation Trust, Derby, Not set

NHS Greater Glasgow and Clyde, Glasgow, Not set

University College London Hospitals, London, Not set

East and North Hertfordshire NHS Trust, Middlesex, Not set

Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, Not set

Conditions: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer

Learn More ›

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

NCT01711541

Completed

This partially randomized phase I/II trial studies the side effects and best dose of veliparib when given together with combination chemotherapy and to see how well they work in treating patients with stage IV head and neck cancer. Drugs used in chemotherapy, such as docetaxel, cisplatin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Veliparib may stop the growth of tumo... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/06/2023

Locations: Northwestern University, Chicago, Illinois +4 locations

Conditions: Head and Neck Squamous Cell Carcinoma, Stage IVA Oropharyngeal Carcinoma AJCC v7, Stage IVB Oropharyngeal Carcinoma AJCC v7

Learn More ›

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

NCT00002826

Completed

RATIONALE: Some tumors become resistant to chemotherapy drugs. Combining PSC 833 with a chemotherapy drug may reduce resistance to the drug, and allow the tumor cells to be killed. PURPOSE: Phase II trial to study the effectiveness of PSC 883 and paclitaxel in treating women who have recurrent or metastatic breast cancer.

Gender:

FEMALE

Ages:

Between 18 years and 120 years

Trial Updated:

06/05/2023

Locations: Veterans Affairs Medical Center - Palo Alto, Palo Alto, California +8 locations

Conditions: Breast Cancer

Learn More ›

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

NCT02784288

Completed

Investigators will determine whether a treatment paradigm of up-front neck dissection, to more accurately pathologically stage patients, minimizing the number of treatment modalities in patients with low risk oropharyngeal squamous cell carcinoma, can improve quality of life.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/01/2023

Locations: University of Michigan Cancer Center, Ann Arbor, Michigan

Conditions: Oropharyngeal Squamous Cell Cancer

Learn More ›

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

NCT03567720

Active Not Recruiting

This is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study. Cohort 1 will be a single-arm study of intratumoral tavokinogene telseplasmid (TAVO) plus electroporation (EP) in combination with pembrolizumab therapy. Cohort 2 will be a single-arm study of intratumoral TAVO-EP plus pembrolizumab along with treatment of an approved chemotherapy per standard of care (either nab-paclitaxel (Abraxane®) or gemcitabine (Gemzar®) plus carboplatin (Paraplatin®)) in participants with TNBC and no prior s... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/30/2023

Locations: University of Arizona, Tucson, Arizona +13 locations

Conditions: Triple Negative Breast Cancer

Learn More ›

Browse by State

Paclitaxel treatment options in Alabama

Paclitaxel treatment options in Alaska

Paclitaxel treatment options in Arizona

Paclitaxel treatment options in Arkansas

Paclitaxel treatment options in California

Paclitaxel treatment options in Colorado

Paclitaxel treatment options in Connecticut

Paclitaxel treatment options in Delaware

Paclitaxel treatment options in District of Columbia

Paclitaxel treatment options in Florida

Paclitaxel treatment options in Georgia

Paclitaxel treatment options in Hawaii

Paclitaxel treatment options in Idaho

Paclitaxel treatment options in Illinois

Paclitaxel treatment options in Indiana

Paclitaxel treatment options in Iowa

Paclitaxel treatment options in Kansas

Paclitaxel treatment options in Kentucky

Paclitaxel treatment options in Louisiana

Paclitaxel treatment options in Maine

Paclitaxel treatment options in Montana

Paclitaxel treatment options in Nebraska

Paclitaxel treatment options in Nevada

Paclitaxel treatment options in New Hampshire

Paclitaxel treatment options in New Jersey

Paclitaxel treatment options in New Mexico

Paclitaxel treatment options in New York

Paclitaxel treatment options in North Carolina

Paclitaxel treatment options in North Dakota

Paclitaxel treatment options in Ohio

Paclitaxel treatment options in Oklahoma

Paclitaxel treatment options in Oregon

Paclitaxel treatment options in Maryland

Paclitaxel treatment options in Massachusetts

Paclitaxel treatment options in Michigan

Paclitaxel treatment options in Minnesota

Paclitaxel treatment options in Mississippi

Paclitaxel treatment options in Missouri

Paclitaxel treatment options in Pennsylvania

Paclitaxel treatment options in Rhode Island

Paclitaxel treatment options in South Carolina

Paclitaxel treatment options in South Dakota

Paclitaxel treatment options in Tennessee

Paclitaxel treatment options in Texas

Paclitaxel treatment options in Utah

Paclitaxel treatment options in Vermont

Paclitaxel treatment options in Virginia

Paclitaxel treatment options in Washington

Paclitaxel treatment options in West Virginia

Paclitaxel treatment options in Wisconsin

Paclitaxel treatment options in Wyoming